Home » Topics » Disease categories and therapies » Immune

Immune
RSS

More on Enanta's ciclosporin analogues with improved toxicity profiles

June 6, 2003

Statin-derived LFA-1 inhibitor proves effective as an immunosuppressant in mice

June 4, 2003

Novartis presents efficacy and safety data for fully human anti-CD154 MAb

June 4, 2003

NC-1153: a novel immunosuppressant that selectively targets Jak3

June 3, 2003

Orally active, small-molecule CXCR3 antagonist represents a new class of transplant therapeutics

June 3, 2003

Multiferon use expanded in Mexico

June 2, 2003

Valentis licenses delivery technology to Juvaris

May 26, 2003

New immunosuppressive compound under development at Isotechnika

May 23, 2003

Immune-selective proteasome inhibitors under study at Kyorin and Nisshin Pharma

May 22, 2003

Thalidomide delays sepsis in an experimental model

May 22, 2003

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...